HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.

AuthorsMartin Oman Evans 2nd, Michael J Morris, Christopher Albert Coop, Sara Ellen Evans
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 115 Issue 3 Pg. 250-1 (Sep 2015) ISSN: 1534-4436 [Electronic] United States
PMID26162570 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Allergic Agents
  • Anti-Asthmatic Agents
  • Omalizumab
Topics
  • Adult
  • Anti-Allergic Agents (therapeutic use)
  • Anti-Asthmatic Agents (adverse effects, therapeutic use)
  • Aspergillosis, Allergic Bronchopulmonary (drug therapy, immunology)
  • Aspergillus fumigatus (immunology)
  • Asthma (drug therapy)
  • Female
  • Humans
  • Omalizumab (adverse effects, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: